Association between novel Glucose-Lowering drugs and risk of Asthma: A network Meta-Analysis of cardiorenal outcome trials-Reference-Cited by-同舟云学术

Association between novel Glucose-Lowering drugs and risk of Asthma: A network Meta-Analysis of cardiorenal outcome trials

Published:2022-01 Issue: Volume:183 Page:109080
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Wang Aihua,Tang Huilin,Zhang Ning,Feng Xin

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Immunology of asthma and chronic obstructive pulmonary disease;Barnes;Nat Rev Immunol,2008

2. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer;Ehrlich;Diabetes Care,2010

3. The impact of therapy on the risk of asthma in type 2 diabetes;Rayner;Clin Respir J,2019

4. Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology;Bloodworth;J Allergy Clin Immunol,2018

5. The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship;Colice;Pragmat Obs Res,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity-related asthma and its relationship with microbiota;Frontiers in Cellular and Infection Microbiology;2024-01-15

2. Empagliflozin inhibits autophagy and mitigates airway inflammation and remodelling in mice with ovalbumin-induced allergic asthma;European Journal of Pharmacology;2023-07

3. Diabetic endothelial microangiopathy and pulmonary dysfunction;Frontiers in Endocrinology;2023-03-21

4. Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study;BMC Medicine;2023-02-10

5. Association of Sodium-Glucose Cotransporter 2 Inhibitor vs Dipeptidyl Peptidase-4 Inhibitor Use With Risk of Incident Obstructive Airway Disease and Exacerbation Events Among Patients With Type 2 Diabetes in Hong Kong;JAMA Network Open;2023-01-17